Basal Ganglia T1 Hyperintensity in Hereditary Hemorrhagic Telangiectasia

References

1. 1.↵
   2. Shovlin CL,
   3. Guttmacher AE,
   4. Buscarini E, et al

   . Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66–67 pmid:10751092

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Pagon RA,
   2. Adam MP,
   3. Ardinger HH, et al.

   2. McDonald J,
   3. Pyeritz RE

   . Hereditary hemorrhagic telangiectasia. In: Pagon RA, Adam MP, Ardinger HH, et al., eds. GeneReviews. Seattle: University of Washington; 1993–2017. http://www.ncbi.nlm.nih.gov/books/NBK1351/. Accessed March 1, 2017. pmid:20301525
3. 3.↵
   2. Brinjikji W,
   3. Wood CP,
   4. Lanzino G, et al

   . High rates of bleeding complications among hospitalized patients with hereditary hemorrhagic telangiectasia in the United States. Ann Am Thorac Soc 2016;13:1505–11 doi:10.1513/AnnalsATS.201603-200OC pmid:27387823

   CrossRefPubMed
4. 4.↵
   2. Shovlin CL

   . Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 2010;24:203–19 doi:10.1016/j.blre.2010.07.001 pmid:20870325

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Letteboer TG,
   3. Mager JJ,
   4. Snijder RJ, et al

   . Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 2006;43:371–77 pmid:16155196

   Abstract/FREE Full Text
6. 6.↵
   2. Sabbà C,
   3. Pasculli G,
   4. Lenato GM, et al

   . Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost 2007;5:1149–57 doi:10.1111/j.1538-7836.2007.02531.x pmid:17388964

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Brinjikji W,
   3. Iyer VN,
   4. Wood CP, et al

   . Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis. J Neurosurg 2016 Oct 21. [Epub ahead of print] doi:10.3171/2016.7.JNS16847 pmid:27767404

   CrossRefPubMed
8. 8.↵
   2. Mandzia J,
   3. Henderson K,
   4. Faughnan M, et al

   . Compelling reasons to screen brain in HHT. Stroke 2001;32:2957–58 pmid:11740006

   FREE Full Text
9. 9.↵
   2. Kobayashi Z,
   3. Tani Y,
   4. Watabiki S, et al

   . Brain MRI of hereditary hemorrhagic telangiectasia (HHT) with intrahepatic arteriovenous shunts. Intern Med 2005;44:773–74 doi:10.2169/internalmedicine.44.773 pmid:16093611

   CrossRefPubMed
10. 10.↵
    2. Baba Y,
    3. Ohkubo K,
    4. Hamada K, et al

    . Hyperintense basal ganglia lesions on T1-weighted images in hereditary hemorrhagic telangiectasia with hepatic involvement. J Comput Assist Tomogr 1998;22:976–79 doi:10.1097/00004728-199811000-00024 pmid:9843242

    CrossRefPubMed
11. 11.↵
    2. Oikonomou A,
    3. Chatzistefanou A,
    4. Zezos P, et al

    . Basal ganglia hyperintensity on T1-weighted MRI in Rendu-Osler-Weber disease. J Magn Reson Imaging 2012;35:426–30 doi:10.1002/jmri.22892 pmid:22127848

    CrossRefPubMed
12. 12.↵
    2. Maeda H,
    3. Sato M,
    4. Yoshikawa A, et al

    . Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain. Neuroradiology 1997;39:546–50 doi:10.1007/s002340050464 pmid:9272489

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Komiyama M,
    3. Terada A,
    4. Ishiguro T, et al

    . Neuroradiological manifestations of hereditary hemorrhagic telangiectasia in 139 Japanese patients. Neurol Med Chir (Tokyo) 2015;55:479–86 doi:10.2176/nmc.oa.2015-0040 pmid:26041630

    CrossRefPubMed
14. 14.↵
    2. Singh S,
    3. Swanson KL,
    4. Hathcock MA, et al

    . Identifying the presence of clinically significant hepatic involvement in hereditary haemorrhagic telangiectasia using a simple clinical scoring index. J Hepatol 2014;61:124–31 doi:10.1016/j.jhep.2014.02.028 pmid:24607625

    CrossRefPubMed
15. 15.↵
    2. Shin YC,
    3. Kim E,
    4. Cheong HK, et al

    . High signal intensity on magnetic resonance imaging as a predictor of neurobehavioral performance of workers exposed to manganese. Neurotoxicology 2007;28:257–62 doi:10.1016/j.neuro.2006.03.014 pmid:16647136

    CrossRefPubMed
16. 16.↵
    2. Faughnan ME,
    3. Palda VA,
    4. Garcia-Tsao G, et al

    ; HHT Foundation International–Guidelines Working Group. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011;48:73–87 doi:10.1136/jmg.2009.069013 pmid:19553198

    Abstract/FREE Full Text